Patents by Inventor Oliver Hasselwander

Oliver Hasselwander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS FOR METABOLIC HEALTH
    Publication number: 20230181653
    Abstract: Provided herein, inter alia, are compositions comprising one or more biologically pure strains of bacteria as well as methods of making and using the same to treat and/or prevent one or more obesity related disorders in a subject m need thereof.
    Type: Application
    Filed: April 5, 2021
    Publication date: June 15, 2023
    Inventors: Sofia FORSSTEN, Oliver HASSELWANDER, Ashley Ann HIBBERD, Henrik Max JENSEN, Helene M A KANE, Hye-Sook KIM, Ritesh KUMAR, Arthur OUWEHAND, Pia Tuulikki RASINKANGAS, Pierre E ROUVIERE, Buffy L STAHL, Qiong WANG
  • PROCESS FOR PRODUCING PULVERULENT PHYTOSTEROL FORMULATIONS
    Publication number: 20090047355
    Abstract: A process for the production of pulverulent phytosterol formulations, includes preparing an aqueous solution, suspension or dispersion of the phytosterol in an aqueous molecular dispersion or colloidal dispersion of a protective colloid and drying.
    Type: Application
    Filed: October 23, 2008
    Publication date: February 19, 2009
    Applicant: BASF Aktiengesellschaft
    Inventors: Helmut Auweter, Heribert Bohn, Oliver Hasselwander, Frank Runge
  • Crystalline choline ascorbate
    Patent number: 7320803
    Abstract: Crystalline ascorbate, in particular choline ascorbate in the form of crystals free from water of crystallization, processes for its preparation, and its used are described.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: January 22, 2008
    Assignee: BASF Aktiengesellschaft
    Inventors: Ludwig Völkel, Alfred Oftring, Oliver Hasselwander, Ulrike Sindel, Klaus Krämer
  • Preparation for improved dietary utilisation
    Patent number: 7304089
    Abstract: Food, feed or drug preparations are described that contain conjugated trans/cis-octadecatrienoic acid, and processes are described for their production. Inventive preparations preferably comprise calendic acid. The invention also relates to the use of the preparations to reduce food intake in humans and animals and to improve food utilization.
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: December 4, 2007
    Assignee: BASF Aktiengesellschaft
    Inventors: Klaus Krämer, Oliver Hasselwander, Uwe Oberfrank
  • Choline ascorbate formulations
    Publication number: 20060153912
    Abstract: The invention relates to novel choline ascorbate-containing formulations; processes for their preparation and their use in human or animal foods, or human or animal food supplements or pharmaceuticals.
    Type: Application
    Filed: September 22, 2003
    Publication date: July 13, 2006
    Applicant: BASF Aktiengesellschaft
    Inventors: Andreas Habich, Morten Hansen, Carsten Hansen, Brigitte Yde, Alfred Oftring, Michael Schoenherr, Felicitas Guth, Oliver Hasselwander
  • Pulverulent phytosterol formulations
    Publication number: 20060035871
    Abstract: A pulverulent phytosterol formulation comprising at least one phytosterol having a mean particle size ranging from 0.01 to 100 ?m, a process for producing the pulverulent phytosterol formulation, and a food supplement, an animal feed, food or pharmaceutical or cosmetic preparation comprising the phytosterol formulation.
    Type: Application
    Filed: November 11, 2003
    Publication date: February 16, 2006
    Applicant: BASF Aktiengesellschaft
    Inventors: Helmut Auweter, Heribert Bohn, Oliver Hasselwander, Frank Runge
  • Compositions containing folic acid and reduced folate
    Patent number: 6921754
    Abstract: Compositions are proposed which comprise folic acid in combination with 5-methyltetrahydrofolic acid, and also compositions which comprise folic acid, 5-methyltetrahydrofolic acid and/or 5-methyltetrahydrofolylpolyglutamate and also comprise a dietary component and/or a nutrient preparation, and their use is also proposed.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: July 26, 2005
    Assignee: BASF Aktiengesellschaft
    Inventors: Wolfgang Hähnlein, Klaus Krämer, Oliver Hasselwander, Loni Schweikert
  • Powder formulation comprising conjugated octadecapolyenic acids
    Publication number: 20050118208
    Abstract: The present invention relates to pulverulent formulations comprising at least one conjugated trans/-cis-octadecapolyenoic acid and also production and use thereof for use in foods, food supplements, feedstuffs, feed additives, pharmaceutical and cosmetic preparations.
    Type: Application
    Filed: November 27, 2002
    Publication date: June 2, 2005
    Applicant: BASF Aktiengesellschaft
    Inventors: Wolfgang Bewert, Morton Mohr Hansen, Oliver Hasselwander, Ulrike Sindel, Arne Ptock, Willy Hinz, Angelika-Maria Pfeiffer, Andreas Habich, Bruno Kaesler
  • Preparation for improved dietary utilisation
    Publication number: 20040047894
    Abstract: Food, feed or drug preparations are described that contain conjugated trans/cis-octadecatrienoic acid, and processes are described for their production. Inventive preparations preferably comprise calendic acid. The invention also relates to the use of the preparations to reduce food intake in humans and animals and to improve food utilization.
    Type: Application
    Filed: July 3, 2003
    Publication date: March 11, 2004
    Inventors: Klause Kramer, Oliver Hasselwander, Uwe Oberfrank
  • Combination of lipoic acids and conjugated acids for treating diabetic disorders
    Publication number: 20030187058
    Abstract: The present invention relates to the use of lipoic acid, a physiologically acceptable derivative or salt thereof and one compound of the formula I
    Type: Application
    Filed: March 5, 2003
    Publication date: October 2, 2003
    Inventors: Oliver Hasselwander, Klaus Kramer, Kai-Uwe Baldenius, Martin Jochen Klatt, Loni Schweikert
  • Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system
    Publication number: 20030148991
    Abstract: The present invention relates to the use of lipoic acid and C1 donors, in particular S-adenosylmethionine and/or 5-methyltetrahydrofolate, for the treatment of central nervous system disorders, to compositions with a corresponding active ingredient combination and to compositions in the form of commercial packs with corresponding combination products or single component products for combined use.
    Type: Application
    Filed: November 7, 2002
    Publication date: August 7, 2003
    Inventors: Wolfgang P Hahnlein, Klaus Kramer, Oliver Hasselwander, Walter E Muller, Gunther P Eckert
  • Compositions containing folic acid and reduced folate
    Publication number: 20030143304
    Abstract: Compositions are proposed which comprise folic acid in combination with 5-methyltetrahydrofolic acid, and also compositions which comprise folic acid, 5-methyltetrahydrofolic acid and/or 5-methyltetrahydrofolylpolyglutamate and also comprise a dietary component and/or a nutrient preparation, and their use is also proposed.
    Type: Application
    Filed: November 7, 2002
    Publication date: July 31, 2003
    Inventors: Wolfgang Hahnlein, Klaus Kramer, Oliver Hasselwander, Loni Schweikert
  • Crystalline choline ascorbate
    Publication number: 20020161039
    Abstract: Crystalline ascorbate, in particular choline ascorbate in the form of crystals free from water of crystallization, processes for its preparation, and its used are described.
    Type: Application
    Filed: February 19, 2002
    Publication date: October 31, 2002
    Inventors: Ludwig Volkel, Alfred Oftring, Oliver Hasselwander, Ulrike Sindel, Klaus Kramer